Innovative Clinical Solutions, Ltd., a service provider for the pharmaceutical and managed care industries, retained Shields & Company to render a fairness opinion to its Board of Directors. Following the transaction, the Clinical Studies, Ltd. division of the company became a wholly-owned subsidiary of Comprehensive NeuroScience, Inc., a privately-held clinical knowledge company focused on the development, evaluation, and appropriate use of drugs used to treat neuropsychiatric illnesses.
Shields & Company rendered a fairness opinion to the Board of Directors of Innovative Clinical Solutions, Ltd. regarding this transaction.
